FDA Testing Uncovers Hidden Ingredient (Image Credits: Unsplash)
Lorton, Virginia — Akkarco LLC announced a voluntary recall of its Ashfiat Alharamain Energy Support product after FDA testing detected undeclared tadalafil, the active ingredient in the prescription medication Cialis.[1][2]
FDA Testing Uncovers Hidden Ingredient
FDA laboratory analysis confirmed the presence of tadalafil in the supplement, which had not been listed on the label.[3] This discovery prompted the recall, initiated following an FDA alert from October 2025 that first warned consumers about the potential harm from the product.[1] The company acted after receiving notification from regulators. No confirmed adverse health events have surfaced so far. Tadalafil belongs to a class of drugs known as phosphodiesterase-5 inhibitors, approved only for specific medical uses under professional supervision.
Products like this cannot legally market themselves as dietary supplements when they contain prescription-level pharmaceuticals. The recall covers a specific batch distributed nationwide. Akkarco LLC conducted the action with FDA knowledge, posting the announcement on January 28, 2026.[1]
Serious Health Concerns Linked to Tadalafil
Tadalafil treats erectile dysfunction but carries risks when used without medical oversight. It can cause cardiovascular complications, sudden blood pressure drops, dizziness, and headaches.[2] Individuals with conditions like diabetes, high blood pressure, high cholesterol, or heart disease face heightened dangers, especially if they take nitrates such as nitroglycerin. These interactions may lower blood pressure to life-threatening levels.
The FDA emphasizes that such undeclared ingredients turn supplements into unapproved new drugs. Consumers often purchase these for energy boosts, unaware of the pharmaceutical content. Health professionals urge caution with similar products marketed for vitality or performance.[3]
Identifying the Recalled Product
Ashfiat Alharamain Energy Support comes in a glass bottle featuring an orange label. Check the back for these exact details to confirm if you have the affected item:
- UPC: 1234561870003
- Batch Number: ENCOT24
- Expiration Date: OCT 2028
The product marketed itself as a honey-based energy aid, sold through online channels. Distribution reached consumers across the United States via the company’s website at akkarco.com and platforms like Amazon.com.[1] Retail stores may also carry it.
Steps for Consumers and Next Actions
Anyone with the product should stop using it immediately. Return it to the point of purchase or dispose of it according to seller instructions. Report any adverse effects to the FDA’s MedWatch program online or by calling 1-800-FDA-0178.[3]
For questions, contact the recall coordinator at office@unitedlegalexperts.com, available Monday through Friday from 8 a.m. to 4 p.m. EST. Media inquiries go to Shahzaib Amin Malik. Full details appear on the FDA recall page.[1]
- Undeclared tadalafil makes this energy supplement an unapproved drug.
- Risks include dangerous blood pressure drops and heart issues.
- Check batch ENCOT24 on orange-labeled glass bottles and discard immediately.
This incident highlights the importance of scrutinizing supplement labels and sticking to regulated products. Regulatory vigilance protects public health from hidden hazards. What do you think about this recall? Tell us in the comments.
